Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 4×
“developed by Amidon et al.(1) and is known as the Biopharmaceutics Classification System (BCS).”
BackgroundInfluentialSelf-citationArtursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
Kasim, N. A., Whitehouse, M., Ramachandran, C., Bermejo, M., Lennernäs, H., Hussain, A. S., Junginger, H. E., Stavchansky, S. A., Midha, K. K., Shah, V. P., et al. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034006h · Cited by 847 · cited 7×
“In a provisional classification of the WHO Essential Drugs, this API was also classified to be BCS Class I.(8) So, from a scientific point of view this API is a candidate for granting a biowaiver when the IR tablets are formulatedwith well-known excipients, show rapid in vitro dissolution, and meet the dissolution pro…”
BackgroundMethodInfluentialSelf-citationArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571 · cited 1×
“8, as is recently suggested in general.(25) In a provisional classification of the WHO Essential Drugs, verapamilwas classified to beBCSClass I.”
BackgroundSelf-citationLennernaäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970332a · Cited by 500 · cited 1×
“A higher permeability observed in the intestinal perfusion technique may be due to a lower paracellular transport and/or a larger area available for absorption in vivo in humans, as it is assumed that the absorption of hydrophilic compounds is so slow that a larger surface area of the intervillous space is exposed.(48…”
BackgroundHilgendorf, C., Spahn‐Langguth, H., Regårdh, C. G., Lipka, E., Amidon, G. L., & Langguth, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<63::aid-jps7>3.0.co;2-6 · Cited by 480
Self-citationWiniwarter, S., Bonham, N. M., Ax, F., Hallberg, A., Lennernäs, H., & Karlén, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810102 · Cited by 453
Pharmacology of Antihypertensive Drugs.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-650_9 · Cited by 325
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Walter, E., Janich, S., Roessler, B. J., Hilfinger, J. M., & Amidon, G. L. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960110x · Cited by 273
Self-citationGrès, M.-C., Julian, B., Bourrié, M., Meunier, V., Roques, C., Berger, M., Boulenc, X., Berger, Y., & Fabre, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919003030 · Cited by 243
[The European directorate for the quality of medicines].
Artiges, A. (2001) · PubMed · Cited by 201
Link between drug absorption solubility and permeability measurements in Caco-2 cells
Pade, V., & Stavchansky, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980111k · Cited by 186
Pade, V., & Stavchansky, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012111008617 · Cited by 185 · cited 1×
“Beside this, propranolol is lipophilic enough to take advantage of the large surface area for transcellular permeation.(31) Using a different cell line, TC-7 (which is a clone of Caco-2, displaying increased tauro-cholic acid transport) similar Peff values were obtained.”
ResultArtursson, P., & Magnusson, C. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790710 · Cited by 183
Lennernäs, H., Nylander, S., & Ungell, A.-L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012121632357 · Cited by 173
Flux Measurements across Caco-2 Monolayers May Predict Transport in Human Large Intestinal Tissue
Rubas, W., Cromwell, M. E. M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., & Mrsny, R. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950267+ · Cited by 160 · cited 1×
“7 10 6 cm/s was found by Rubas et al.(47) that was significantly higher than those values reported by the other groups.”
ResultBlume, H. H., & Schug, B. S. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00076-7 · Cited by 152
Doppenschmitt, S., Spahn‐Langguth, H., Regårdh, C. G., & Langguth, P. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980378j · Cited by 127
Clinical pharmacokinetics of atenolol — A review
Kirch, W., & Görg, K. G. (1982) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188723 · Cited by 110
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917060-00001 · Cited by 106
Jejunal Absorption and Metabolism of R/S-Verapamil in Humans
Sandström, R., Karlsson, A., Knutson, L., & Lennernäs, H. (1998) · Pharmaceutical Research · doi:10.1023/a:1011916329863 · Cited by 101
Lennernas, H., Ahrenstedt, O., & Ungell, A. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04309.x · Cited by 101 · cited 1×
“A higher permeability observed in the intestinal perfusion technique may be due to a lower paracellular transport and/or a larger area available for absorption in vivo in humans, as it is assumed that the absorption of hydrophilic compounds is so slow that a larger surface area of the intervillous space is exposed.(48…”
BackgroundCollett, A., Sims, E. J., Walker, D., He, Y., Ayrton, J., Rowland, M., & Warhurst, G. (1996) · Pharmaceutical Research · doi:10.1023/a:1016082829111 · Cited by 88
Jejunal permeability and hepatic extraction of fluvastatin in humans
Lindahl, A., Sandström, R., Ungell, A.-L., Abrahamsson, B., Knutson, T. W., Knutson, L., & Lennernäs, H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90145-9 · Cited by 77
Sandström, R., Knutson, T. W., Knutson, L., Jansson, B., & Lennernäs, H. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00999.x · Cited by 77
Dollery, S. C. (1992) · Cited by 74
Food-induced reduction in bioavailability of atenolol
Melander, A., Stenberg, P. B., Liedholm, H., Scherst�n, B., & W�hlin-Boll, E. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00605630 · Cited by 74 · cited 2×
“Excretion is essentially complete after 48hafter administration of a single dose.(56) The total body clearance of atenolol is about 100 mL/min/1.”
BackgroundTakamatsu, N., Welage, L. S., Idkaidek, N., Liu, D.-Y., Lee, P. I.-D., Hayashi, Y., Rhie, J. K., Lennernäs, H., Barnett, J. L., Shah, V. P., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012134219095 · Cited by 60
Self-citationKoninklijke Nederlandse Maatschappij ter bevordering der Pharmacie
Meulenhoff, J. S., & Sloot, H. A. (1980) · Pharmacy World & Science · doi:10.1007/bf02272959 · Cited by 60
Walgren, R. A., & Walle, T. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991773366 · Cited by 25 · cited 1×
“However, propranolol is avidly bound to plasmaprotein, and this resulted in a significant decrease of the exsorption (from basolateral to apical) of propranolol.(33) Permeability values obtained in vivo by the intestinal perfusion technique were about 10–20fold higher than obtained by Caco-2.”
Result
Cited by
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
Self-citationNovel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds
BRUSEWITZ, C., SCHENDLER, A., FUNKE, A., WAGNER, T., & LIPP, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.022 · Cited by 86
Metadata
- Authors
- Vogelpoel, H., Welink, J., Amidon, G. L., Junginger, H. E., Midha, K. K., Möller, H., Olling, M., Shah, V. P., & Barends, D. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 93
- Issue
- 8
- Pages
- 1945-1956
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2169939486
- Cited by
- 179
- References
- 34
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.